Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity

Find Full text
Publication year
2019
Author(s)
Lamers-Karnebeek, F.B.G.
Jacobs, Johannes W. G.
Radstake, T.R.D.J.
Riel, P.L.C.M. van
Jansen, Tim L.
Source
Rheumatology, 58, 3, (2019), pp. 427-431
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/202471   https://hdl.handle.net/2066/202471
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.